Aurinia Pharmaceuticals Inc.·4/A

Feb 22, 4:19 PM ET

Robertson Stephen P. 4/A

4/A · Aurinia Pharmaceuticals Inc. · Filed Feb 22, 2024

Insider Transaction Report

Form 4/AAmended
Period: 2023-03-02
Robertson Stephen P.
EVP, General Counsel
Transactions
  • Sale

    Common Stock

    2023-03-02$8.78/sh19,644$172,474303,122 total
Footnotes (1)
  • [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.

Documents

1 file
  • 4
    wk-form4a_1708636769.xml

    FORM 4/A